A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(9 sites)

United States

Torrance Memorial, Torrance, California

St. Anthony Hospital, Lakewood, Colorado

Georgetown University, Washington D.C., District of Columbia

University Of Chicago, Chicago, Illinois

Indiana University, Indianapolis, Indiana

University of Louisville, Louisville, Kentucky

Washington University, St Louis, Missouri

Atrium Health Carolinas Medical Center, Charlotte, North Carolina

The Ohio State University Medical Center, Columbus, Ohio